The CDC's Division of Blood Disorders is hosting a webinar on the Evaluation and Management of Fertility in People with Thalassemia, scheduled for November 5 from 2:00-3:00 PM ET. Farzana Sayani, MD, MSc, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and Director, Penn Comprehensive Adult Thalassemia Program, will serve as faculty.
The thalassemia syndromes are a common genetic disorder due to hemoglobin gene deletions leading to severe anemia. Long-term transfusions, the mainstay of therapy in transfusion-dependent thalassemia, lead to significant tissue iron overload and increased morbidity and mortality. Improved comprehensive care, iron chelators, and improved monitoring methods have helped decrease complications due to iron overload.
As care is improving, more individuals with thalassemia are reaching adulthood with aspirations to start a family of their own. However, infertility is one of the major complications of iron overload in patients with thalassemia.
In this webinar, Dr. Sayani will review the causes of infertility in individuals with thalassemia. She will also discuss methods to preserve and evaluate fertility, management options for infertility, and other options available to start a family.
- List the causes of infertility in individuals with thalassemia.
- Identify the key method to preserve fertility in individuals with thalassemia.
- Describe the treatment options for individuals with thalassemia who suffer from infertility.
This webinar is free and open to public health professionals, clinicians, and researchers who desire more information about thalassemia. Advance registration is required, and the number of attendees is limited.
Please pre-register here: http://bit.ly/ThalFertility